Jan 02, 2024
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.40 to $0.02.
The split itself did not change the total investment value.
Pasithea Therapeutics Corp. (KTTA) trades on the NASDAQ Capital Market in the Biotechnology industry.
Pasithea Therapeutics Corp. company overviewThe latest split shown was on January 2, 2024. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on January 2, 2024.